F
Francesco Arcoleo
Publications - 3
Citations - 605
Francesco Arcoleo is an academic researcher. The author has contributed to research in topics: Hereditary angioedema & Icatibant. The author has an hindex of 3, co-authored 3 publications receiving 541 citations.
Papers
More filters
Journal ArticleDOI
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
Marco Cicardi,Aleena Banerji,F. Bracho,Alejandro Malbrán,Bernd Rosenkranz,Marc A. Riedl,Konrad Bork,William R. Lumry,Werner Aberer,Henning Bier,Murat Bas,Jens Greve,Thomas K. Hoffmann,Henriette Farkas,Avner Reshef,Bruce Ritchie,William H. Yang,Jürgen Grabbe,Shmuel Kivity,Wolfhart Kreuz,Robyn J. Levy,Thomas A. Luger,Krystyna Obtułowicz,Peter Schmid-Grendelmeier,Christian Bull,Brigita Sitkauskiene,William B Smith,Elias Toubi,Sonja Werner,Suresh Anné,Janne Björkander,Laurence Bouillet,Enrico Cillari,D. Hurewitz,Kraig W. Jacobson,Constance H. Katelaris,Marcus Maurer,Hans F. Merk,Jonathan A. Bernstein,Conleth Feighery,Bernard Floccard,Gerald J. Gleich,Jacques Hébert,Martin Kaatz,Paul K. Keith,Charles H. Kirkpatrick,David Langton,Ludovic Martin,Christiane Pichler,David Resnick,Duane Wombolt,Diego S. Fernández Romero,Andrea Zanichelli,Francesco Arcoleo,Jochen Knolle,Irina Kravec,Liying Dong,Jens Zimmermann,Kimberly Rosen,Wing Tze Fan +59 more
TL;DR: In patients with hereditary angioedema having acute attacks, a significant benefit of icatibant as compared with tranexamic acid in one trial and a nonsignificantbenefit of ic atibant in the other trial are found with regard to the primary end point.
Journal ArticleDOI
Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.
Andrea Zanichelli,Hilary Longhurst,Marcus Maurer,Laurence Bouillet,Werner Aberer,Vincent Fabien,Irmgard Andresen,Teresa Caballero,W. Aberer,Anete Sevciovic Grumach,Anette Bygum,C. Blanchard Delaunay,L. Bouillet,Brigitte Coppere,Olivier Fain,B. Goichot,Anne Gompel,Sophie Guez,Pierre-Yves Jeandel,Gisèle Kanny,D. Launay,H. Maillard,Ludovic Martin,A. Masseau,Y. Ollivier,Alain Sobel,J. Arnolds,Emel Aygören-Pürsün,Murat Bas,Andrea Bauer,Konrad Bork,I. Martinez,Marcus Maurer,Efimia Papadopoulou-Alataki,Fotis Psarros,Y. Graif,Shmuel Kivity,Avner Reshef,Elias Toubi,Francesco Arcoleo,Marco Cicardi,P. Manconi,Gianni Marone,Vincenzo Montinaro,Maria L. Baeza,T. Caballero,Rosario Cabañas,Mar Guilarte,D. Hernandez de Rojas,C. Hernando de Larramendi,R. Lleonart,T. Lobera,B. Sáenz de San Pedro,Janne Björkander,Matthew Helbert,Hilary Longhurst +55 more
TL;DR: About 50% of patients with C1-INH-HAE type I or II have previously had their conditions misdiagnosed, most commonly as allergic angioedema or appendicitis, which results in marked delays in receiving the correct diagnosis.
Journal ArticleDOI
Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study
Murat Bas,Jens Greve,Thomas K. Hoffmann,Avner Reshef,Werner Aberer,Marcus Maurer,Shmuel Kivity,Henriette Farkas,Bernard Floccard,Francesco Arcoleo,Ludovic Martin,Brigita Sitkauskiene,Laurence Bouillet,Peter Schmid-Grendelmeier,Huamin Henry Li,Andrea Zanichelli +15 more
TL;DR: Evaluated the efficacy and safety of repeated treatment with icatibant in adult patients experiencing HAE attacks during the FAST‐2 open‐label extension (OLE) phase.